Cargando…

Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy

SIMPLE SUMMARY: Unfavorable results following radical cystectomy for bladder cancer (BCa) highlights a critical need for a novel prognostic molecular biomarker with potential therapeutic benefits. In the present study, the expression levels of AHNAK2 in specimens obtained by radical cystectomy were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koguchi, Dai, Matsumoto, Kazumasa, Shimizu, Yuriko, Kobayashi, Momoko, Hirano, Shuhei, Ikeda, Masaomi, Sato, Yuichi, Iwamura, Masatsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069489/ https://www.ncbi.nlm.nih.gov/pubmed/33918555 http://dx.doi.org/10.3390/cancers13081748

Ejemplares similares

Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
por: Katsumata, Hiroki, et al.
Publicado: (2023)

Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
por: Shimura, Soichiro, et al.
Publicado: (2021)

DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer
por: Hirano, Shuhei, et al.
Publicado: (2022)

Gemcitabine–Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
por: Koguchi, Dai, et al.
Publicado: (2022)

Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study
por: Koguchi, Dai, et al.
Publicado: (2022)

Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
por: Mori, Kohei, et al.
Publicado: (2022)

Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer
por: Mori, Kohei, et al.
Publicado: (2023)

Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study
por: Koguchi, Dai, et al.
Publicado: (2020)

Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review
por: Koguchi, Dai, et al.
Publicado: (2022)

Nestin Is an Independent Predictor of Cancer-Specific Survival after Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder
por: Tabata, Ken-ichi, et al.
Publicado: (2014)

Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study
por: Tachibana, Takashi, et al.
Publicado: (2023)

The impact of real-time 3d imaging by ultra-high speed optical coherence tomography in urothelial carcinoma
por: Ikeda, Masaomi, et al.
Publicado: (2013)

National database of patients treated with radical cystectomy provides a current standard and comparison for future technologies
por: Matsumoto, Kazumasa
Publicado: (2018)

AHNAK2 is a potential prognostic biomarker in patients with PDAC
por: Lu, Di, et al.
Publicado: (2017)

Prognostic factors in radical cystectomy affecting survival
por: Aglamis, Erdogan, et al.
Publicado: (2012)

The Obscure Potential of AHNAK2
por: Zardab, Mohamed, et al.
Publicado: (2022)

AHNAKs roles in physiology and malignant tumors
por: Zhang, Shusen, et al.
Publicado: (2023)

AHNAK2 is a biomarker and a potential therapeutic target of adenocarcinomas: AHNAK2 is a biomarker for adenocarcinomas
por: Xu, Meng, et al.
Publicado: (2022)

Radical cystectomy in octogenarians
por: Rawal, Sudhir, et al.
Publicado: (2012)

Laparoscopic radical cystectomy
por: Fergany, Amr
Publicado: (2012)

Intranodal Lymphangiography during Surgical Repair of Pelvic Lymphorrhea after Radical Cystectomy
por: Onishi, Yasuyuki, et al.
Publicado: (2021)

Prognostic Value of an Immunohistochemical Signature in Patients With Bladder Cancer Undergoing Radical Cystectomy
por: Wu, Jie, et al.
Publicado: (2021)

Is robot-assisted radical cystectomy superior to standard open radical cystectomy? An Indian perspective
por: Ram, Dharma, et al.
Publicado: (2018)

Effect of cisplatin on metastatic castration-resistant prostate cancer with BRCA2 mutation: A case report
por: Koguchi, Dai, et al.
Publicado: (2021)

Laparoscopic radical and partial cystectomy
por: Challacombe, Ben J., et al.
Publicado: (2005)

Prognostic features for quality of life after radical cystectomy and orthotopic neobladder
por: Kretschmer, Alexander, et al.
Publicado: (2016)

Cost comparison between open radical cystectomy, laparoscopic radical cystectomy, and robot-assisted radical cystectomy for patients with bladder cancer: a systematic review of segmental costs
por: Morii, Yasuhiro, et al.
Publicado: (2019)

Initial experience with 161 extraperitoneal laparoscopic radical cystectomy procedures: Comparison with transabdominal laparoscopic radical cystectomy
por: Yang, Han, et al.
Publicado: (2022)

Cost-Effectiveness of Robot-Assisted Radical Cystectomy vs Open Radical Cystectomy for Patients With Bladder Cancer
por: Dixon, Simon, et al.
Publicado: (2023)

Myosteatosis as a novel prognostic biomarker after radical cystectomy for bladder cancer
por: Yamashita, Shimpei, et al.
Publicado: (2020)

Complications of Radical Cystectomy and Orthotopic Reconstruction
por: Tan, Wei Shen, et al.
Publicado: (2015)

Challenges facing regionalization of radical cystectomy
por: Cahn, David B., et al.
Publicado: (2018)

Radical cystectomy and urinary diversion in women
por: von Knobloch, Rolf
Publicado: (2023)

The learning curve for robot-assisted radical cystectomy with total intracorporeal urinary diversion based on radical cystectomy pentafecta
por: Noh, Tae Il, et al.
Publicado: (2022)

AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma
por: Wang, Minglei, et al.
Publicado: (2017)

The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy
por: Lee, Joong Sub, et al.
Publicado: (2015)

Prognostic factors for conditional survival in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy
por: Kang, Minyong, et al.
Publicado: (2015)

AHNAK and Inflammatory Markers Predict Poor Survival in Laryngeal Carcinoma
por: Dumitru, Claudia A., et al.
Publicado: (2013)

AHNAK as a Prognosis Factor Suppresses the Tumor Progression in Glioma
por: Zhao, Zijin, et al.
Publicado: (2017)

Impact of Histopathological Variant on the Outcome of Patients Treated by Radical Cystectomy
por: Nadeem, Mehwash, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8sc6m2cr0fnm2bea838nnts89i